EcoR1 Capital is a fund manager in San Francisco with $4.44 bn assets under management.
Company profile
Website
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
SEC advisor number
801-100470
FINRA CRD number
167121
AUM ?
$5.00 bn
(as of 28 Mar 24)
Accounts
5
(as of 28 Mar 24)
Employees
21
(8 investment advisory or research)
Address
EcoR1 Capital
357 TEHAMA STREET #3
SAN FRANCISCO
CA 94103
357 TEHAMA STREET #3
SAN FRANCISCO
CA 94103
Phone
415-448-6534
Brochures
Ownership
Fund structure | AUM | Fund type |
---|---|---|
ECOR1 Capital, LLC | $4.44 bn | |
ECOR1 Capital Fund Qualified, L.P. | $3.87 bn | Hedge Fund |
ECOR1 Capital Offshore Fund, LTD. | ||
ECOR1 Capital Fund, L.P. | $422.58 mm | Hedge Fund |
ECOR1 Venture Opportunity Fund, LP | $148.36 mm | Venture Capital Fund |
ECOR1 Venture Opportunity Offshore Fund, LP |
Latest filings (excl ownership)
No filings
Latest ownership filings
SC 13G/A
LENZ Therapeutics, Inc.
8 Apr 24
3
Adaptimmune Therapeutics PLC
26 Mar 24
SC 13G/A
Adaptimmune Therapeutics PLC
26 Mar 24
SC 13G
Crinetics Pharmaceuticals, Inc.
11 Mar 24
SC 13D
Zymeworks Inc.
22 Feb 24
SC 13G
iTeos Therapeutics, Inc.
16 Feb 24
SC 13G/A
Morphic Holding, Inc.
15 Feb 24
SC 13G/A
Atea Pharmaceuticals, Inc.
15 Feb 24
SC 13G/A
Atea Pharmaceuticals, Inc.
15 Feb 24
SC 13G/A
Atea Pharmaceuticals, Inc.
14 Feb 24
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
26 Dec 23 | EcoR1 Capital | Pre-Funded Warrants Common Stock | Buy | Acquire P | Yes | No | 9.8299 | 5,086,521 | 50.00 mm | 5,086,521 |
21 Sep 23 | Nodelman Oleg | Class A Common Stock | Buy | Acquire P | Yes | No | 1.3611 | 53,000 | 72.14 k | 12,674,775 |
20 Sep 23 | Nodelman Oleg | Class A Common Stock | Buy | Acquire P | Yes | No | 1.362 | 117,100 | 159.49 k | 12,621,775 |
19 Sep 23 | Nodelman Oleg | Class A Common Stock | Buy | Acquire P | Yes | No | 1.2562 | 5,143,000 | 6.46 mm | 12,504,675 |